Australia's largest stock trading and investment forum Australia's #1 stock forum

MSB

7.22%

90.0¢ mesoblast limited

CEO Itescu needs to go, page-192

First 192 Last

Share
Profile

Follow
whytee

16,764 Posts.

2392

07/08/23

11:10

Post #: 69196969
Share

Originally posted by dolcevita ↑

You're a seasoned analyst. That doesn't give you a monopoly on logic nor on this particular field.

See the Bell Potter analyst above who describes the FDA approach as 'confusing'. I think this is putting it mildly.

When I say that it's unethical to require a full adult trial I mean this in ALL the circumstances.

Which part of this did you not understand

You say that the patients are not abandoned. This is not good enough is it? Not when their mortality remains so massive.

Tell that to the patient, not to me. You are deprived of the best possible treatment, but don't worry, you will not be in pain and have palliative care.

You could be in the 20% that survives, give it a go?

THAT"S what I mean about ethics. But you conflate this into a generic and irresponsible claim that I am somehow against double blind clinical trials, presumably when I'm in the mood.

Not when there is a therapy that's already demonstrated to reverse the mortality rate.

Not when pharmaceutical drugs are waved through on lesser proof, with more damaging potential.

No. This is a stitch up.

Everyone has an ego and yours has been exposed.

Nothing you say justifies skewering Silviu Itescu at this crucial stage.

Sorry but you're now lead in the saddle and I never thought
a) I'd come into conflict with you,
b) that you'd get so personal and so insulting
c) that you'd be calling for SI's scalp
d) that you'd confuse statements that are about a range of possibilities, with statements of fact.
I have a legal background. Do not misrepresent my statements it is not appreciated.

Strange days, but I will leave the last words to Bell Potter. I think they sum up the inconsistencies well. They also left out the inconsistencies with the bewildering refusal to follow the 9-1 recommendations of the expert panel, which is why we are here.

What I am clear on is that the behaviour of the FDA is inconsistent at best. That we had legal avenues and followed them up, and will continue to do so.

Finally on abandonment. I regretted your decision to abandon us in this forum, and urged you to return. Suddenly at this crucial stage you now you decide to swoop back. You should have never left but your ego kept you away. I urged you to not over react to what happened.
Instead of restraint you are pouring oil on the fire.
You of all people must know that retail investors would
a) never have the numbers to cause a spill
b) sell in fright.

Retail investors are waking in fright but someone is mopping up their shares. You are not helping.

Don't lecture me about emotion.

Expand

Your misunderstanding is that your null hypothesis is that "Remestemcel works"

The FDA and the scientific world use the null hypothesis "The cells don't work"
They also consider the correct alternative hypothesis is "The cells do work", but it needs to be proven in a properly conducted RCT.

MSB Price at posting: 46.0¢ Sentiment: Sell Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

STK

Strickland picks up 4g/t gold across 89 metres at Serbia's Shanac

Diggers & Dealers 2024: Kim Beazley ties mining and military together; highlights competition with China in Africa

APS

Allup Silica spotlights ilmenite in acquisition of WA valuable heavy mineral sand project

Money and Investing with Andrew Baxter: The psychology and emotion driving bulls and bears

HCL

HighCom receives new body armour worth just short of $9M

There are more pages in this discussion • 716 more messages in this thread...

First 192 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last 90.0¢		Change -0.070(7.22%)		Mkt cap ! $1.033B

Open	High	Low	Value	Volume
95.0¢	95.0¢	90.0¢	$7.467M	8.132M

Buyers (Bids)

No.	Vol.	Price($)
12	32412	90.0¢

Sellers (Offers)

Price($)	Vol.	No.
90.5¢	231517	37

View Market Depth

No.	Vol.	Price($)
6	67778	0.900
16	377883	0.895
21	317763	0.890
10	198797	0.885
24	756944	0.880

Price($)	Vol.	No.
0.905	232702	37
0.910	164715	22
0.915	77920	14
0.920	103892	7
0.925	41047	6

Last trade - 14.52pm 05/08/2024 (20 minute delay)

MSB (ASX) Chart

CEO Itescu needs to go, page-192

Strickland picks up 4g/t gold across 89 metres at Serbia's Shanac

Diggers & Dealers 2024: Kim Beazley ties mining and military together; highlights competition with China in Africa

Allup Silica spotlights ilmenite in acquisition of WA valuable heavy mineral sand project

Money and Investing with Andrew Baxter: The psychology and emotion driving bulls and bears

HighCom receives new body armour worth just short of $9M

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

CEO Itescu needs to go, page-192

Top Stories

Strickland picks up 4g/t gold across 89 metres at Serbia's Shanac

Diggers & Dealers 2024: Kim Beazley ties mining and military together; highlights competition with China in Africa

Allup Silica spotlights ilmenite in acquisition of WA valuable heavy mineral sand project

Money and Investing with Andrew Baxter: The psychology and emotion driving bulls and bears

HighCom receives new body armour worth just short of $9M

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News